Loading…
Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus
Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenz...
Saved in:
Published in: | The Journal of infectious diseases 2017-03, Vol.215 (6), p.847-855 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83 |
---|---|
cites | cdi_FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83 |
container_end_page | 855 |
container_issue | 6 |
container_start_page | 847 |
container_title | The Journal of infectious diseases |
container_volume | 215 |
creator | Martínez-Baz, Iván Casado, Itziar Navascués, Ana Díaz-González, Jorge Aguinaga, Aitziber Barrado, Laura Delfrade, Josu Ezpeleta, Carmen Castilla, Jesús |
description | Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenza-like illness were tested for influenza. Four periods with continued A(H1N1)pdm09 circulation were included in a test-negative design. Results. We enrolled 1278 cases and 2343 controls. As compared to individuals never vaccinated against influenza A(H1N1) pdm09, the highest effectiveness (66%; 95% confidence interval, 49%–78%) was observed in those vaccinated in the current season who had received 1–2 prior doses. The effectiveness was not statistically lower in individuals vaccinated in the current season only (52%) or in those without current vaccination and >2 prior doses (47%). However, the protection was lower in individuals vaccinated in the current season after >2 prior doses (38%; P = .009) or those currently unvaccinated with 1–2 prior doses (10%; P < .001). Current-season vaccination improved the effect in individuals with 1–2 prior doses and did not modify significantly the risk of influenza in individuals with >2 prior doses. Conclusion. Current vaccination or several prior doses were needed for high protection. Despite the decreasing effect of repeated vaccination, current-season vaccination was not inferior to no current-season vaccination. |
doi_str_mv | 10.1093/infdis/jix055 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1893545620</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26167016</jstor_id><oup_id>10.1093/infdis/jix055</oup_id><sourcerecordid>26167016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83</originalsourceid><addsrcrecordid>eNqFkE1v1DAQQC0EotvCkSPIx_YQOrbXdnJcrUpbqSqIj3KMvPaYepXYIXYkyq9vUBZ65GDNwU9vNI-QNwzeM2jEeYjehXy-D79AymdkxaTQlVJMPCcrAM4rVjfNETnOeQ8Aa6H0S3LE67UU81uR7sJ7tIUmTz_jgKago3fG2hBNCSnS76Hc03KP9Ivp8fCDdJv6IUWMhW5-mBBzoRygoZ9MdNgHS6-j7yaMvw3dnF6xW3ZG78I45VfkhTddxteHeUK-fbj4ur2qbj5eXm83N5UVtS6VrmvBuGg4aKkd14KDAi1YY0Ax75UD6xizTCFjvBaOzycaqSTudk42vhYn5HTxDmP6OWEubR-yxa4zEdOU25kXci0VhxmtFtSOKecRfTuMoTfjQ8ug_RO4XQK3S-CZf3dQT7se3T_6b9Gn3Wka_ut6u6D7XNL4pFJMaWBKPAK_dY0D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1893545620</pqid></control><display><type>article</type><title>Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus</title><source>Oxford Journals Online</source><creator>Martínez-Baz, Iván ; Casado, Itziar ; Navascués, Ana ; Díaz-González, Jorge ; Aguinaga, Aitziber ; Barrado, Laura ; Delfrade, Josu ; Ezpeleta, Carmen ; Castilla, Jesús</creator><creatorcontrib>Martínez-Baz, Iván ; Casado, Itziar ; Navascués, Ana ; Díaz-González, Jorge ; Aguinaga, Aitziber ; Barrado, Laura ; Delfrade, Josu ; Ezpeleta, Carmen ; Castilla, Jesús</creatorcontrib><description>Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenza-like illness were tested for influenza. Four periods with continued A(H1N1)pdm09 circulation were included in a test-negative design. Results. We enrolled 1278 cases and 2343 controls. As compared to individuals never vaccinated against influenza A(H1N1) pdm09, the highest effectiveness (66%; 95% confidence interval, 49%–78%) was observed in those vaccinated in the current season who had received 1–2 prior doses. The effectiveness was not statistically lower in individuals vaccinated in the current season only (52%) or in those without current vaccination and >2 prior doses (47%). However, the protection was lower in individuals vaccinated in the current season after >2 prior doses (38%; P = .009) or those currently unvaccinated with 1–2 prior doses (10%; P < .001). Current-season vaccination improved the effect in individuals with 1–2 prior doses and did not modify significantly the risk of influenza in individuals with >2 prior doses. Conclusion. Current vaccination or several prior doses were needed for high protection. Despite the decreasing effect of repeated vaccination, current-season vaccination was not inferior to no current-season vaccination.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/jix055</identifier><identifier>PMID: 28453845</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Humans ; Influenza A Virus, H1N1 Subtype ; Influenza Vaccines - administration & dosage ; Influenza Vaccines - therapeutic use ; Influenza, Human - epidemiology ; Influenza, Human - prevention & control ; Logistic Models ; Male ; Middle Aged ; Spain ; Vaccination ; VIRUSES ; Young Adult</subject><ispartof>The Journal of infectious diseases, 2017-03, Vol.215 (6), p.847-855</ispartof><rights>Copyright © 2017 Oxford University Press on behalf of the Infectious Diseases Society of America</rights><rights>The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2017</rights><rights>The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83</citedby><cites>FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28453845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez-Baz, Iván</creatorcontrib><creatorcontrib>Casado, Itziar</creatorcontrib><creatorcontrib>Navascués, Ana</creatorcontrib><creatorcontrib>Díaz-González, Jorge</creatorcontrib><creatorcontrib>Aguinaga, Aitziber</creatorcontrib><creatorcontrib>Barrado, Laura</creatorcontrib><creatorcontrib>Delfrade, Josu</creatorcontrib><creatorcontrib>Ezpeleta, Carmen</creatorcontrib><creatorcontrib>Castilla, Jesús</creatorcontrib><title>Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenza-like illness were tested for influenza. Four periods with continued A(H1N1)pdm09 circulation were included in a test-negative design. Results. We enrolled 1278 cases and 2343 controls. As compared to individuals never vaccinated against influenza A(H1N1) pdm09, the highest effectiveness (66%; 95% confidence interval, 49%–78%) was observed in those vaccinated in the current season who had received 1–2 prior doses. The effectiveness was not statistically lower in individuals vaccinated in the current season only (52%) or in those without current vaccination and >2 prior doses (47%). However, the protection was lower in individuals vaccinated in the current season after >2 prior doses (38%; P = .009) or those currently unvaccinated with 1–2 prior doses (10%; P < .001). Current-season vaccination improved the effect in individuals with 1–2 prior doses and did not modify significantly the risk of influenza in individuals with >2 prior doses. Conclusion. Current vaccination or several prior doses were needed for high protection. Despite the decreasing effect of repeated vaccination, current-season vaccination was not inferior to no current-season vaccination.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Case-Control Studies</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Humans</subject><subject>Influenza A Virus, H1N1 Subtype</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Influenza Vaccines - therapeutic use</subject><subject>Influenza, Human - epidemiology</subject><subject>Influenza, Human - prevention & control</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Spain</subject><subject>Vaccination</subject><subject>VIRUSES</subject><subject>Young Adult</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkE1v1DAQQC0EotvCkSPIx_YQOrbXdnJcrUpbqSqIj3KMvPaYepXYIXYkyq9vUBZ65GDNwU9vNI-QNwzeM2jEeYjehXy-D79AymdkxaTQlVJMPCcrAM4rVjfNETnOeQ8Aa6H0S3LE67UU81uR7sJ7tIUmTz_jgKago3fG2hBNCSnS76Hc03KP9Ivp8fCDdJv6IUWMhW5-mBBzoRygoZ9MdNgHS6-j7yaMvw3dnF6xW3ZG78I45VfkhTddxteHeUK-fbj4ur2qbj5eXm83N5UVtS6VrmvBuGg4aKkd14KDAi1YY0Ax75UD6xizTCFjvBaOzycaqSTudk42vhYn5HTxDmP6OWEubR-yxa4zEdOU25kXci0VhxmtFtSOKecRfTuMoTfjQ8ug_RO4XQK3S-CZf3dQT7se3T_6b9Gn3Wka_ut6u6D7XNL4pFJMaWBKPAK_dY0D</recordid><startdate>20170315</startdate><enddate>20170315</enddate><creator>Martínez-Baz, Iván</creator><creator>Casado, Itziar</creator><creator>Navascués, Ana</creator><creator>Díaz-González, Jorge</creator><creator>Aguinaga, Aitziber</creator><creator>Barrado, Laura</creator><creator>Delfrade, Josu</creator><creator>Ezpeleta, Carmen</creator><creator>Castilla, Jesús</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170315</creationdate><title>Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus</title><author>Martínez-Baz, Iván ; Casado, Itziar ; Navascués, Ana ; Díaz-González, Jorge ; Aguinaga, Aitziber ; Barrado, Laura ; Delfrade, Josu ; Ezpeleta, Carmen ; Castilla, Jesús</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Case-Control Studies</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Humans</topic><topic>Influenza A Virus, H1N1 Subtype</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Influenza Vaccines - therapeutic use</topic><topic>Influenza, Human - epidemiology</topic><topic>Influenza, Human - prevention & control</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Spain</topic><topic>Vaccination</topic><topic>VIRUSES</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez-Baz, Iván</creatorcontrib><creatorcontrib>Casado, Itziar</creatorcontrib><creatorcontrib>Navascués, Ana</creatorcontrib><creatorcontrib>Díaz-González, Jorge</creatorcontrib><creatorcontrib>Aguinaga, Aitziber</creatorcontrib><creatorcontrib>Barrado, Laura</creatorcontrib><creatorcontrib>Delfrade, Josu</creatorcontrib><creatorcontrib>Ezpeleta, Carmen</creatorcontrib><creatorcontrib>Castilla, Jesús</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez-Baz, Iván</au><au>Casado, Itziar</au><au>Navascués, Ana</au><au>Díaz-González, Jorge</au><au>Aguinaga, Aitziber</au><au>Barrado, Laura</au><au>Delfrade, Josu</au><au>Ezpeleta, Carmen</au><au>Castilla, Jesús</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>2017-03-15</date><risdate>2017</risdate><volume>215</volume><issue>6</issue><spage>847</spage><epage>855</epage><pages>847-855</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenza-like illness were tested for influenza. Four periods with continued A(H1N1)pdm09 circulation were included in a test-negative design. Results. We enrolled 1278 cases and 2343 controls. As compared to individuals never vaccinated against influenza A(H1N1) pdm09, the highest effectiveness (66%; 95% confidence interval, 49%–78%) was observed in those vaccinated in the current season who had received 1–2 prior doses. The effectiveness was not statistically lower in individuals vaccinated in the current season only (52%) or in those without current vaccination and >2 prior doses (47%). However, the protection was lower in individuals vaccinated in the current season after >2 prior doses (38%; P = .009) or those currently unvaccinated with 1–2 prior doses (10%; P < .001). Current-season vaccination improved the effect in individuals with 1–2 prior doses and did not modify significantly the risk of influenza in individuals with >2 prior doses. Conclusion. Current vaccination or several prior doses were needed for high protection. Despite the decreasing effect of repeated vaccination, current-season vaccination was not inferior to no current-season vaccination.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>28453845</pmid><doi>10.1093/infdis/jix055</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 2017-03, Vol.215 (6), p.847-855 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_1893545620 |
source | Oxford Journals Online |
subjects | Adolescent Adult Aged Aged, 80 and over Case-Control Studies Child Child, Preschool Female Humans Influenza A Virus, H1N1 Subtype Influenza Vaccines - administration & dosage Influenza Vaccines - therapeutic use Influenza, Human - epidemiology Influenza, Human - prevention & control Logistic Models Male Middle Aged Spain Vaccination VIRUSES Young Adult |
title | Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A16%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Repeated%20Vaccination%20With%20the%20Same%20Vaccine%20Component%20Against%202009%20Pandemic%20Influenza%20A(H1N1)%20Virus&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Mart%C3%ADnez-Baz,%20Iv%C3%A1n&rft.date=2017-03-15&rft.volume=215&rft.issue=6&rft.spage=847&rft.epage=855&rft.pages=847-855&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/jix055&rft_dat=%3Cjstor_proqu%3E26167016%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-7883123920757d27320607319a061ff6d0cd11c16e11283d2189a565ebbd59f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1893545620&rft_id=info:pmid/28453845&rft_jstor_id=26167016&rft_oup_id=10.1093/infdis/jix055&rfr_iscdi=true |